Heather Lamberg Kafele

Winston & Strawn (Washington)
Lawyer (Partner)

Heather Kafele is a partner in the Washington, D.C. office of Winston. She has extensive experience in complex litigation, investigations, and regulatory proceedings with a particular emphasis on complex antitrust, competition and consumer issues. She has represented plaintiffs and defendants in a variety of antitrust cases, including monopolization, price-fixing (cartel), predatory pricing, bundling, tying, false advertising, unfair competition and leveraging cases. Ms. Kafele also has handled worldwide internal investigations of cartel activity. She frequently represents companies and individuals in criminal cartel cases before the Department of Justice. Ms. Kafele has launched a website that monitors international cartel enforcement at www.carteldigest.com and frequently counsels and speaks on anti-cartel compliance. In addition to antitrust litigation, Ms. Kafele also represents clients in a variety of commercial litigation and arbitration matters, including bankruptcy cases, contract disputes, false advertising cases, judgment enforcement matters, and foreign corrupt practices act investigations.

Distinctions

Linked authors

Shearman & Sterling (New York)
Shearman & Sterling (New York)
Shearman & Sterling (Shanghaï)
Shearman & Sterling (New York)
The Capitol Forum (Washington)
Paul Hastings (San Francisco)
Shearman & Sterling (Washington)
Winston & Strawn (Washington)

Articles

1509 Bulletin

Beau W. Buffier, Heather Lamberg Kafele, Wayne Dale Collins The US Federal Trade Commission revises and raises the thresholds for the Hart-Scott-Rodino Antitrust Improvements Act of 1976

158

The US Federal Trade Commission (“FTC”) has revised and, once again, raised the thresholds for the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the “HSR Act”). The HSR Act may require that parties to proposed stock or asset acquisitions exceeding certain thresholds file (...)

Heather Lamberg Kafele, Keith Palfin The U.S. Court of Appeals for the Second Circuit addresses pharmaceutical “product hopping” in decision barring a producer from pulling older version of drug from shelves (Actavis)

97

Few courts have addressed antitrust challenges to pharmaceutical “product hopping,” i.e., the practice of shifting customers from a drug nearing the end of its patent protection to a modified version that is covered by newer patents and thus is protected from generic competition for a longer (...)

Beau W. Buffier, Heather Lamberg Kafele, Karina Lubell, Mark Lanpher, Steve L. Camahort The U.S. FTC clears a merger between the two most-visited online home shopping sites in the U.S. without conditions (Zillow / Trulia)

85

In a ruling on February 13, the FTC unconditionally approved the Zillow-Trulia merger after an intensive six-month antitrust review. Despite reported concerns “that the merger might concentrate too much power in one company,” the FTC ultimately decided to “bless” the Zillow-Trulia combination. (...)

Beau W. Buffier, Heather Lamberg Kafele, Stephen Mavroghenis The US Court of Appeals for the 7th Circuit rules that a cellphones manufacturer cannot recover overcharges to its non-U.S. subsidiaries that purchased price-fixed LCD panels abroad, even though finished cellphones incorporating those panels were ultimately sold in the U.S. (Motorola / AU Optronics)

925

The Seventh Circuit Court of Appeals ruled that Motorola cannot recover overcharges to its non-U.S. subsidiaries that purchased price-fixed LCD panels abroad, even though finished cellphones incorporating those panels were ultimately sold in the United States. The Court held that (...)

Adam S. Hakki, Beau W. Buffier, Brian G. Burke, Heather Lamberg Kafele, Jerome S. Fortinsky, Richard F. Schwed, Stephen Fishbein, Stephen Mavroghenis The US Eastern District of New York Federal Court awards plaintiffs $162 million in first-ever civil price-fixing verdict against Chinese companies (Vitamin C Cartel)

122

On March 14, 2013, a federal jury in Brooklyn, New York returned a verdict in In re Vitamin C Antitrust Litigation, No. 1:06-md-1738 (E.D.N.Y.), finding that two Chinese companies had unlawfully fixed prices and controlled the supply of vitamin C exports from China to the United States. (...)

Beau W. Buffier, Heather Lamberg Kafele, Jessica K. Delbaum, Kelly Karapeytan, Kenneth S. Prince, Lisl J. Dunlop, Wayne Dale Collins The US FTC fines company for failing to file a premerger notification and observe the statutory waiting period (Biglari)

122

Passive Investors Beware: Recent FTC Fine Affirms Narrow Scope of HSR Exemption * In fining Biglari Holdings $850,000 for failing to file a premerger notification and observe the statutory waiting period in connection with its 2011 purchase of shares of Cracker Barrel, the FTC affirmed that it (...)

Send a message